Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation
Số trang: 9
Loại file: pdf
Dung lượng: 1.90 MB
Lượt xem: 22
Lượt tải: 0
Xem trước 1 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Several studies showed that lack of CD56 expression was a poor prognostic factor for patients with newly diagnosed multiple myeloma (NDMM). However, other studies were not able to confirm the prognostic value of CD56 in NDMM. This study aimed to evaluate the prognostic value of CD56 expression for patients with NDMM who received autologous stem cell transplantation (ASCT).
Nội dung trích xuất từ tài liệu:
Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation
Nội dung trích xuất từ tài liệu:
Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Multiple myeloma Autologous stem cell transplantation CD56 expression Prognostic value CD56 negative patientsGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 142 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 118 0 0 -
12 trang 93 0 0
-
19 trang 74 0 0
-
17 trang 64 0 0
-
9 trang 43 0 0
-
12 trang 38 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 37 0 0